Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study of V600 BRAF Mutation in Spanish Patients Diagnosed With Metastatic Melanoma: ABSOLUT-BRAF Study

NCT02663232 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02663232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02663232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study of V600 BRAF Mutation in Spanish Patients Diagnosed With Metastatic Melanoma: ABSOLUT-BRAF Study
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
June 30, 2013
Completion date
October 31, 2014
Enrollment
264 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancers